Gapping down
In reaction to disappointing earnings/guidance: SILC -5%, DB -4.4%, MRVL -4.2%, SOHU -3.8%, MNDO -2.3%, IBN -1.6%
M&A news: AMAT -6% (Applied Materials and Tokyo Electron (TOELY) agree to terminate business combination agreement; announces $3 bln share repurchase authorization), BP -1% (UK Government has indicated that it would not approve any acquisition of BP, according to FT)
Other news: CLDN -74.5% (reports negative results for CUPID2 trial of MYDICAR in advanced heart failure; investigational gene therapy fails to meet primary and secondary endpoints), AKRX -12.4% (announces it will restate various previously issued financial statements due to errors identified during the first quarter 2015 financial review process; affirms its 2015 EPS guidance),RMGN -10.6% (announces the appointment of Jana Bell as CFO), CO -5.8% (announces receipt of 'going private' proposal from Golden Meditech Holdings for $6.40/share in cash), ATRS -4.4% (regains U.S. marketing rights to OTREXUP for psoriasis indication and announces termination of leo pharma marketing agreement), CWST -1.1% (postponed the date of 2015 Annual Meeting of Stockholders, previously scheduled to be held on July 7, 2015, to a date to be determined), NOK -0.8% (reaffirms it currently has no plans to manufacture or sell consumer handsets)
Analyst comments: DDD -2.5% (downgraded to Underweight from Neutral at Piper Jaffray; downgraded to Sell from Neutral at UBS), SDRL -1.7% (downgraded to Sell from Neutral at Citigroup; downgraded to Underperform from Market Perform at Wells Fargo), EV -1.6% (downgraded to Sell from Neutral at Citigroup), SSYS -1.3% (downgraded to Hold from Buy at Canaccord Genuity),OHI -1% (downgraded to Underperform from Neutral at BofA/Merrill), PRGO -0.9% (downgraded to Neutral from Buy at UBS; downgraded to Neutral at B. Riley & Co), TWTR -0.6% (downgraded to Neutral from Buy at Sun Trust Rbsn Humphrey)
In reaction to disappointing earnings/guidance: SILC -5%, DB -4.4%, MRVL -4.2%, SOHU -3.8%, MNDO -2.3%, IBN -1.6%
M&A news: AMAT -6% (Applied Materials and Tokyo Electron (TOELY) agree to terminate business combination agreement; announces $3 bln share repurchase authorization), BP -1% (UK Government has indicated that it would not approve any acquisition of BP, according to FT)
Other news: CLDN -74.5% (reports negative results for CUPID2 trial of MYDICAR in advanced heart failure; investigational gene therapy fails to meet primary and secondary endpoints), AKRX -12.4% (announces it will restate various previously issued financial statements due to errors identified during the first quarter 2015 financial review process; affirms its 2015 EPS guidance),RMGN -10.6% (announces the appointment of Jana Bell as CFO), CO -5.8% (announces receipt of 'going private' proposal from Golden Meditech Holdings for $6.40/share in cash), ATRS -4.4% (regains U.S. marketing rights to OTREXUP for psoriasis indication and announces termination of leo pharma marketing agreement), CWST -1.1% (postponed the date of 2015 Annual Meeting of Stockholders, previously scheduled to be held on July 7, 2015, to a date to be determined), NOK -0.8% (reaffirms it currently has no plans to manufacture or sell consumer handsets)
Analyst comments: DDD -2.5% (downgraded to Underweight from Neutral at Piper Jaffray; downgraded to Sell from Neutral at UBS), SDRL -1.7% (downgraded to Sell from Neutral at Citigroup; downgraded to Underperform from Market Perform at Wells Fargo), EV -1.6% (downgraded to Sell from Neutral at Citigroup), SSYS -1.3% (downgraded to Hold from Buy at Canaccord Genuity),OHI -1% (downgraded to Underperform from Neutral at BofA/Merrill), PRGO -0.9% (downgraded to Neutral from Buy at UBS; downgraded to Neutral at B. Riley & Co), TWTR -0.6% (downgraded to Neutral from Buy at Sun Trust Rbsn Humphrey)